Katherine S. Tweden

Katherine S. Tweden, PhD is the Vice President, Clinical Sciences at Senseonics, Inc.

Katherine has more than 25 years in research, clinical and regulatory affairs. At Senseonics, she is responsible for all clinical affairs, including conducting all U.S. and global clinical trials for existing and future CGM systems.

Prior to Senseonics, Katherine guided a novel class III active implantable obesity medical device from invention through FDA approval at EnteroMedics Inc. as one of the co-inventors and founders. Since 1990, she worked in the medical device industry in research and development roles in the fields of coronary vascular disease, heart valve disease and periodontal ligament regeneration at HeartStent Corporation, St Jude Medical, Inc and W.L. Gore and Associates, respectively. Katherine has more than 60 patents and publications.

Katherine received her Master of Science and PhD in biomedical engineering from Iowa State University and has post-doctorates in oral biology and surface chemistry from State University of New York at Buffalo.